Impact of gain-of-function mutations in the low-density lipoprotein receptor-related protein 5 (LRP5) on glucose and lipid homeostasis
ConclusionsAlthough our sample size was small, our data do not support the hypothesis that HBM-causing LRP5 mutations, associated with increased Wnt signaling, improve glucose metabolism in humans. However, it does appear that LRP5 variants may affect LDL metabolism, a major risk factor for coronary artery disease. The molecular mechanisms underpinning this effect warrant further study.
Source: Osteoporosis International - Category: Orthopaedics Source Type: research
More News: Academia | Cholesterol | Diabetes | Diabetes Type 2 | Endocrinology | Insulin | Orthopaedics | Osteoporosis | Pancreas | Statistics | Study